News & Events Biome Diagnostics mentioned in Financial TimesVIENNA, December 2021: For the first time in the history of the company, Biome Diagnostics…Barbara SladekJanuary 26, 2022
News & Events Biome Diagnostics again under Top 100 Start-Ups in Austria!VIENNA, November 2021: Biome Diagnostics, previously known as myBioma, has been mentioned as number 51…Barbara SladekJanuary 25, 2022
News & Events Dr. Nikolaus Gasche is under the Top 30 under 30 at Forbes DACHVIENNA, November 2021: Co-Founder Dr. Nikolaus Gasche has been recognised as one of the top…Barbara SladekJanuary 24, 2022
News & Events Cancer and microbiome — the long-awaited holy grail?VIENNA, November 2021 The enormous burden of cancer continues to grow and its impact not…Nikolaus GascheNovember 5, 2021
Press Releases Biome Diagnostics identifies tumor-agnostic biomarker for cancer immunotherapy in a new meta-analysis of microbiome studiesBiome Diagnostics (BiomeDx) presents new meta-analysis which reinforces the significance of the intestinal microbiome as…Nikolaus GascheNovember 2, 2021
News & Events Poster: 8th Theodor Escherich Symposium / 4th AMICI SymposiumBiomeDx presents newest findings on microbiome signatures predicting immune checkpoint inhibitor therapy response. GRAZ, October…Nikolaus GascheOctober 27, 2021
News & Events Poster: 45th annual conference of the Austrian Society for PneumologyBiomeDx presents first meta-analysis for predicting immune checkpoint inhibitor therapy response. VIENNA, October 11th, 2021:…Nikolaus GascheOctober 12, 2021
Publications & Posters ÖGP 2021: Meta-analysis on the specificity of microbiome-based signatures for predicting immune checkpoint inhibitor therapy response in non-small cell lung cancer patientsNikolaus GascheOctober 11, 2021
News & Events Panel discussion: European annual biotech conference Biotech Atelier 2021BiomeDx was invited to present its own research and discuss microbiome and nutrigenetics. September 29th,…Nikolaus GascheSeptember 29, 2021
News & Events 2021/09 BiomeOne study updateVIENNA, September 2021 We are happy to announce that the recruitment for our clinical research…Nikolaus GascheSeptember 7, 2021